-----------------------------
                                                             OMB APPROVAL
                                                   -----------------------------
                                                   OMB Number 3235-0145
                                                   Expires: December 31, 2005
                                                   Estimated average burden
                                                   hours per response ..... 11
                                                   -----------------------------



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                  SCHEDULE 13G


                    UNDER THE SECURITIES EXCHANGE ACT OF 1934*





                              Antares Pharma, Inc.
--------------------------------------------------------------------------------
                                (Name of Issuer)


                         Common Stock, $0.01 par value
--------------------------------------------------------------------------------
                         (Title of Class of Securities)


                                   036642106
 ------------------------------------------------------------------------------
                                 (CUSIP Number)

                                 July 21, 2003
           -----------------------------------------------------------
             (Date of Event which requires filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Statement
is filed:

[ ] Rule 13d-1(b)

[X] Rule 13d-1(c)

[ ] Rule 13d-1(d)

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).




CUSIP No. 036642106                  13G                 Page  2  of  5  Pages

--------------------------------------------------------------------------------

    1       NAME OF REPORTING PERSON
            S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

            North Sound Capital LLC (1)(2)
--------------------------------------------------------------------------------

    2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*           (a) [X]

                                                                        (b) [ ]
--------------------------------------------------------------------------------
    3       SEC USE ONLY


--------------------------------------------------------------------------------

    4       CITIZENSHIP OR PLACE OF ORGANIZATION

            Delaware
--------------------------------------------------------------------------------

                           5      SOLE VOTING POWER
      NUMBER OF                   0
        SHARES     -------------------------------------------------------------
     BENEFICIALLY
       OWNED BY            6      SHARED VOTING POWER
         EACH                     1,000,000
      REPORTING    -------------------------------------------------------------
        PERSON             7      SOLE DISPOSITIVE POWER
         WITH
                                  0
                   -------------------------------------------------------------
                           8      SHARED DISPOSITIVE POWER

                                  1,000,000
--------------------------------------------------------------------------------
    9      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

           1,000,000
--------------------------------------------------------------------------------
   10      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

           [ ]
--------------------------------------------------------------------------------
   11      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

           8.4%
--------------------------------------------------------------------------------
   12      TYPE OF REPORTING PERSON*

           OO
--------------------------------------------------------------------------------
                      *SEE INSTRUCTIONS BEFORE FILLING OUT

(1)  The ultimate managing member of North Sound Capital LLC is Thomas McAuley.
     The Reporting Person may be deemed the beneficial owner of the shares in
     its capacity as the managing member of various funds who are the holders of
     such shares. As the managing member of the funds, the Reporting Person has
     voting and investment control with respect to the shares of common stock
     held by the funds.

(2)  DMG Advisors LLC changed its name to North Sound Capital LLC effective
     April 1, 2003.




CUSIP No. 036642106                  13G                 Page  3  of  5  Pages

--------------------------------------------------------------------------------

ITEM 1(A).        NAME OF ISSUER:

                  Antares Pharma, Inc.

ITEM 1(B).        ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:

                  707 Eagleview Boulevard
                  Suite 414
                  Exton, Pennsylvania 19341

ITEM 2(A).        NAME OF PERSON FILING.
ITEM 2(B).        ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE.
ITEM 2(C).        CITIZENSHIP.

                  North Sound Capital LLC
                  53 Forest Avenue, Suite 202
                  Old Greenwich, CT 06870
                  Delaware limited liability company

ITEM 2(D).        TITLE OF CLASS OF SECURITIES:

                  Common Stock, $0.01 par value

ITEM 2(E).        CUSIP NUMBER:

                  036642106

ITEM 3.           IF THIS STATEMENT IS FILED PURSUANT TO RULES  13D-1(B),  OR
                  13D-2(B), CHECK WHETHER THE PERSON FILING IS A:

                  Not Applicable

ITEM 4.           OWNERSHIP.        As of July 21, 2003:

                  (a) Amount  beneficially  owned:  1,000,000  shares of Common
                      Stock.

                  (b) Percent of Class:8.4%

                  (c) Number of shares as to which such person has:

                           (i)   sole power to vote or direct the vote: 0

                           (ii)  shared  power  to  vote  or  direct  the  vote:
                                 1,000,000

                           (iii) sole power to dispose or direct the disposition
                                 of: 0

                           (iv)  shared   power  to   dispose   or  direct  the
                                 disposition of: 1,000,000



CUSIP No. 036642106                  13G                 Page  4  of  5  Pages

--------------------------------------------------------------------------------

ITEM 5.           OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

                  Not applicable.


ITEM 6.           OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER
                  PERSON.

                  Not applicable.

ITEM 7.           IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
                  ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
                  COMPANY.

                  Not Applicable.

ITEM 8.           IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

                  Not Applicable.

ITEM 9.           NOTICE OF DISSOLUTION OF GROUP.

                  Not Applicable.

ITEM 10.          CERTIFICATION.

                  By signing below,  the Reporting Person certifies that, to the
                  best of its knowledge and belief,  the securities  referred to
                  above were  acquired  and are held in the  ordinary  course of
                  business  and  were  not  acquired  and are not  held  for the
                  purpose of or with the effect of changing or  influencing  the
                  control of the issuer of the  securities and were not acquired
                  and are not held in connection with or as a participant in any
                  transaction having that purpose or effect.


CUSIP No. 036642106                  13G                 Page  5  of  5  Pages

--------------------------------------------------------------------------------


                                    SIGNATURE

     After  reasonable  inquiry  and  to the  best  of  the  Reporting  Person's
knowledge and belief,  the Reporting  Person  certifies that the information set
forth in this statement is true, complete and correct.

Dated: July 24, 2003


                                               NORTH SOUND CAPITAL LLC


                                           By: /s/ Thomas McAuley
                                               ---------------------------------
                                               Name: Thomas McAuley
                                               Title:   Chief Investment Officer